PLUS1
Starpharma Financial Data
| Company name: | Starpharma Holdings Ltd | Status: | Active |
| End of fiscal year: | 30 June 2018 | ISIN | AU000000SPL0 |
| Year established: | 1997 | Company sector name: | Healthcare |
| Trading currency: | AUD | Industry name: | Biotechnology |
| Place of incorporation: | Australia (AU) | Industry group name | Biotechnology |
| Doing business in: | Australia (AU) | Address | 4-6 Southampton Crescent Abbotsford, 3067 |
| Tel.: | +61 385322700 | City/Country: | Melbourne, Australia |
| Fax: | +61 395105955 | Web address: | http://www.starpharma.com |
| Company description: | Starpharma Holdings Ltd is an Australia based company engaged in the business segment of discovery, development, and commercialisation of dendrimers for pharmaceutical, life science, and other applications. The business areas of the firm are VivaGel, drug delivery, and agrochemicals. The products of the firm are based on VivaGel, a dendrimer which has antimicrobial properties. VivaGel is for topical treatment and rapid relief of bacterial vaginosis. The group is also engaged in marketing of VivaGel condom in Australia under Lifestyles Dual Protect brand. In addition, it is also focused on creating novel dendrimer-enhanced versions of 2,4-D which is a global agrochemical. The company’s revenue comprises the licensing, royalty and research revenue from commercial partners. |
| Price | Price change [%] | Bid | Offer | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.67 | +0.00[+0.00%] | 0.67 | 0.66 | - | - | - | 0 |
| Market Cap. | Shares In Issue | Beta | EPS | DPS | PE Ratio | Yield | 52-Wks-Range |
| 246.14M | 371.69M | 0.42 | -0.03 | - | -23.92 | - | 0.62 - 1.55 |
SPL KEY FIGURES (at previous day's close) | |
|---|---|
Yesterday's Close | 0.67 |
PE Ratio | -23.92 |
Market Capitalisation | 246.14M |
Latest Shares Outstanding | 371.69M |
Earnings pS (EPS) | -0.03 |
Dividend pS (DPS) | - |
Dividend Yield | - |
Sales per Employee | - |
Effective Tax Rate | - |
Foreign Sales | - |
Domestic Sales | - |
Selling, General & Adm/tive (SG... | 58.79% |
Research & Devlopment (R&D) as ... | 0.00% |
Gross Profit Margin | 100.00% |
EBITDA Margin | - |
Pre-Tax Profit Margin | - |
Assets Turnover | 15.35% |
Return on Assets (ROA) | -0.16% |
Return on Equity (ROE) | -0.18% |
Return on Capital Invested (ROC... | -0.20% |
Current Ratio | 11.13 |
Leverage Ratio (Assets/Equity) | 1.10% |
Interest Cover | - |
Total Debt/Equity (Gearing Rati... | 0.00% |
LT Debt/Total Capital | 0.00% |
Working Capital pS | 0.14 |
Cash pS | 0.14 |
Book-Value pS | 0.16 |
Tangible Book-Value pS | 0.00 |
Cash Flow pS | - |
Free Cash Flow pS | -0.03 |
Spread | -0.01 |
Gross gearing | 0.00% |
Net Debt | -51.32M |
SPL Balance Sheet Chart (30 June 2018) | ||
|---|---|---|
 | ||
| Period † | High | Low |
|---|---|---|
| 1 Week | 0.75 | 0.625 |
| 1 Month | 0.80 | 0.62 |
| 3 Months | 0.94 | 0.62 |
| 6 Months | 1.36 | 0.62 |
| 1 Year | 1.545 | 0.62 |
| 3 Years | 2.52 | 0.615 |
| 5 Years | 2.52 | 0.615 |
Share price performance previous 3 years |
|---|
Share price performance intraday |
|---|
| Period † | Open | Open Avg. | VWAP | Min Vol | Max Vol | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|---|
| 1 Week | 0.625 | 0.675 | 0.675737 | 156,854 | 1,352,809 | 628,848 | 0.04 | 6.4% |
| 1 Month | 0.725 | 0.702368 | 0.692187 | 155,674 | 1,352,809 | 460,723 | -0.06 | -8.28% |
| 3 Months | 0.94 | 0.774455 | 0.756552 | 79,237 | 2,276,482 | 370,535 | -0.275 | -29.26% |
| 6 Months | 1.26 | 0.906951 | 0.885469 | 79,237 | 2,276,482 | 405,485 | -0.595 | -47.22% |
| 1 Year | 1.52 | 1.0784 | 1.10 | 79,237 | 2,276,482 | 496,231 | -0.855 | -56.25% |
| 3 Years | 1.37 | 1.2622 | 1.38 | 16,427 | 8,683,381 | 593,034 | -0.705 | -51.46% |
| 5 Years | 0.735 | 1.2605 | 1.34 | 16,427 | 8,683,381 | 562,187 | -0.07 | -9.52% |
SPL Growth Ratios (30 June 2018) | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
Diluted EPS growth | - | - | - | - |
Diluted continuous EPS growth | - | - | - | - |
Dividend growth | - | - | - | - |
Equity per share growth | -0.13 | 0.07 | -0.02 | 0.02 |
Revenue growth | 0.27 | 0.68 | 1.86 | 0.10 |
Operating income growth | - | - | - | - |
Net income growth | - | - | - | - |
Net income cont growth | - | - | - | - |
CFO growth | - | - | - | - |
FCF growth | - | - | - | - |
Operating revenue growth | 0.27 | 0.68 | 1.86 | 0.10 |
SPL Income Statement 30 June 2018 (AUD) | |
|---|---|
Total Revenue | 3.812 |
Operating Revenue | 3.812 |
Gross Profit | 3.812 |
Operating Expenses | 15.242 |
Selling,General and Administr... | 2.241 |
General and Administrative Ex... | 2.241 |
OtherGandA | 2.241 |
Research and Development | 10.576 |
Other Operating Expenses | 2.425 |
Operating Income | -11.43 |
Interest Income/Expense,Net-N... | 1.072 |
Interest Income-Non Operating | 1.072 |
Other Income/Expense,Net | 0.073 |
Other Non-Operating Income/Ex... | 0.073 |
Pretax Income | -10.285 |
Provision for Income Tax | 0.00 |
Net Income Available to Commo... | -10.285 |
Net Income | -10.285 |
Net Income Including Noncontr... | -10.285 |
Net Income from Continuing Op... | -10.285 |
Basic EPS | -0.03 |
Basic EPS from Continuing Ope... | -0.03 |
Basic EPS from Discontinued O... | 0.00 |
Diluted EPS | -0.03 |
Diluted EPS from Continuing O... | -0.03 |
Diluted EPS from Discontinued... | 0.00 |
Basic Weighted Average Shares... | 370.136605 |
Diluted Weighted Average Shar... | 370.136605 |
Net Income from Continuing an... | -10.285 |
Normalized Income | -10.285 |
Basic EPS,Continuing and Disc... | -0.03 |
Diluted EPS,Continuing and Di... | -0.03 |
Interest and Dividend Income | 1.072 |
Net Interest Income | 1.072 |
Earning Before Interest and T... | -11.43 |
Earning Before Interest Tax D... | -11.43 |
Net Income from Continuing Op... | -10.285 |
Normalized Basic EPS | -0.03 |
Normalized Diluted EPS | -0.03 |
NormalizedEBITDA | -11.43 |
Tax rate for calculations | 0.00 |
SPL Efficency Ratios (30 June 2018) | |
|---|---|
Days in sales | 466.73 |
Days in inventory | - |
Days in payment | - |
Cash conversion cycle | - |
Receivable turnover | 0.78 |
Inventory turnover | - |
Payable turnover | - |
Fixed assets turnover | 3.87 |
Assets turnover | 0.06 |
ROE | -0.18 |
ROA | -0.16 |
ROIC | -0.20 |
FCF sales ratio | - |
FCF net income ratio | - |
Capital expenditure sales ratio | 0.09 |
SPL Financial Health Ratios (30 June 2018) | |
|---|---|
Current ratio | 11.13 |
Quick ratio | 11.12 |
Debt total capital ratio | 0.00 |
Debt equity ratio | 0.00 |
Financial leverage | 1.10 |
Total debt to equity | 0.00 |
SPL Avearge Growth Ratios Over 5 Years (30 June 2018) | |
|---|---|
Growth ann capital spending | 0.18 |
Growth ann gross profit | 1.86 |
Avg gross margin | 1.00 |
Avg post tax margin | -16.61 |
Avg pre tax marginr | -18.18 |
Avg net profit | -16.61 |
Avg ret commonr | -0.29 |
Avg ret assets | -0.26 |
Avg ret invested capital | -0.31 |
SPL Profitability Ratios (30 June 2018) | |
|---|---|
Gross margin | 1.00 |
Operating margin | -3.00 |
EBT margin | -2.70 |
Tax rate | - |
Net margin | -2.70 |
Sales per employee | - |
EBIT margin | -3.00 |
EBITDA margin | -3.00 |
Normalized net profit margin | -2.70 |
Interest coverage | - |
Inc per employee tot ops | - |
SPL Valuation Ratios (29 June 2018) | |
|---|---|
Sales per share | - |
Growth ann sales per share 5 ye... | - |
Book value per share | 0.15 |
CF per share | -0.05 |
Price to EPS | - |
Ratio PE 5 year high | - |
Ratio PE 5 year low | - |
Price to book | 7.72 |
Price to sales | - |
Price to cash flow | - |
Price to free cash flow | - |
Div rate | - |
Dividend yield | - |
Div payout tot ops | - |
Div payout 5 year | - |
Payout ratio | 0.00 |
Sustainable growth rate | 0.20 |
Cash return | -0.05 |
SPL Balance Sheet 30 June 2018 (AUD) | |
|---|---|
Total Assets | 58.511 |
Current Assets | 57.453 |
Cash,Cash Equivalents,and Sho... | 51.319 |
Cash and Cash Equivalents | 51.319 |
Cash | 3.353 |
Cash Equivalents | 47.966 |
Receivables | 6.097 |
Accounts Receivable | 5.911 |
Other Receivables | 0.186 |
Prepaid Assets and Others | 0.037 |
Total Non-Current Assets | 1.058 |
Net Property,Plant,and Equipm... | 1.058 |
Gross Property,Plant,and Equi... | 4.116 |
Machinery,Furniture/Equipment | 3.514 |
Leasehold and Improvements | 0.602 |
Accumulated Depreciation | -3.058 |
Total Liabilities | 5.234 |
Current Liabilities | 5.164 |
Payables and Accrued Expenses | 3.801 |
Payables | 3.801 |
Accounts Payable | 3.023 |
Other Payable | 0.778 |
Pension and Other Post-Retire... | 0.93 |
Current Debt and Capital Leas... | 0.026 |
Current Portion of Capital Le... | 0.026 |
Deferred Liabilities,Current | 0.407 |
Deferred Revenue,Current | 0.407 |
Total Non-Current Liabilities | 0.07 |
Long Term Debt and Capital Le... | 0.023 |
Long Term Portion of Capital ... | 0.023 |
Employee Benefits | 0.047 |
Pension and Other Postretirem... | 0.047 |
Total Equity | 53.277 |
Stockholder's Equity | 53.277 |
Capital Stock | 193.583 |
Common Stock | 193.583 |
Retained Earnings | -153.746 |
Accumulated Gains/ Losses Not... | 13.44 |
Other Equity Adjustments | 13.44 |
Total Capitalization | 53.277 |
Common Stock Equity | 53.277 |
Capital Lease Obligations | 0.049 |
Net Tangible Assets | 53.277 |
Working Capital | 52.289 |
Invested Capital | 53.277 |
Tangible Book Value | 53.277 |
Total Debt | 0.049 |
Ordinary Shares Number | 370.544775 |
TotalLiabilitiesAsReported | 5.234 |
TotalEquityAsReported | 53.277 |
SPL Cash Flow 30 June 2018 (AUD) | |
|---|---|
Classes of Cash Receipts from... | 6.535 |
Receipts from Customers | 2.788 |
Receipts from Government Gran... | 3.747 |
Classes of Cash Payments | -17.799 |
Payments to Suppliers for Goo... | -17.799 |
Interest Paid, Direct | -4,000.00 |
Interest Received, Direct | 1.067 |
Cash Flow from Investing Acti... | -0.359 |
Cash Flow from Continuing Inv... | -0.359 |
Purchase/Sale of Property,Pla... | -0.359 |
Purchase of Property,Plant an... | -0.359 |
Cash Flow from Financing Acti... | -0.026 |
Cash Flow from Continuing Fin... | -0.026 |
Other Financing Changes, Net | -0.026 |
Cash and Cash Equivalents,End... | 51.319 |
Change in Cash | -10.586 |
Effect of Exchange Rate Chang... | 0.717 |
Cash and Cash Equivalents,Beg... | 61.188 |
Interest Paid, Supplemental D... | 4,000.00 |
Capital Expenditure | -0.359 |
Free Cash Flow | -10.56 |
ChangeinCashSupplementalAsRep... | -10.586 |
